DM
TTPH

Deerfield Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Deerfield Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-22,510
Closed -$8.98M – 142
2014
Q3 		$8.98M Buy
22,510
+7,009
+45% +$1.88M 0.33% 74
2014
Q2 		$4.18M Buy
+15,501
New +$3.33M 0.17% 92
2013
Q3 		– Sell
-27,745
Closed -$3.9M – 134
2013
Q2 		$3.9M Buy
+27,745
New +$4.39M 0.18% 84

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Deerfield Management's TTPH Position: Q4 2014 in Review

Deerfield Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2014, closing a stake of 22,510 shares — an estimated $8.98M sold.

Deerfield Management first reported a position in TTPH in Q2 2013 and held it in 3 quarters. The position peaked at $8.98M in Q3 2014. 96 funds tracked by Wall St. Rank hold TTPH as of Q4 2014.

  • Deerfield Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Deerfield Management sold 22,510 Tetraphase Pharmaceuticals, Inc. shares in Q4 2014, an estimated $8.98M.
  • Deerfield Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • Deerfield Management's Tetraphase Pharmaceuticals, Inc. position peaked at $8.98M in Q3 2014.
  • 96 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2014.

Based on Deerfield Management's 13F filing for Q4 2014, filed 17 Feb 2015.